A Comprehensive Board Review in Hematology and Medical Oncology is organized by The University of Texas MD Anderson Cancer Center and will be held from Sep 14 - 19, 2026.
Overview:
The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.
Objectives:
At the conclusion of this activity, learners will be able to:
Accreditation:
In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation:
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
American Board of Internal Medicine (ABIM):
Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 51.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CE credits claimed for the activity. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved